|
Q3 FY2026
As of Apr 30, 2026
|
Q2 FY2026
As of Jan 31, 2026
|
Q1 FY2026
As of Oct 31, 2025
|
Q4 FY2025
As of Jul 31, 2025
|
Q3 FY2025
As of Apr 30, 2025
|
Q2 FY2025
As of Jan 31, 2025
|
Q1 FY2025
As of Oct 31, 2024
|
Q4 FY2024
As of Jul 31, 2024
|
Q3 FY2024
As of Apr 30, 2024
|
Q2 FY2024
As of Jan 31, 2024
|
Q1 FY2024
As of Oct 31, 2023
|
|
|---|---|---|---|---|---|---|---|---|---|---|---|
| Contract Assets | |||||||||||
| Prepaid Expenses | |||||||||||
| Cash and cash equivalents | |||||||||||
| Accounts receivable | |||||||||||
| Total current assets | |||||||||||
| Computer software | |||||||||||
| Total non-current asset | |||||||||||
| TOTAL ASSETS | |||||||||||
| Current Liabilities | |||||||||||
| Advances from related party | |||||||||||
| Accounts payable | |||||||||||
| Prepaid sales | |||||||||||
| Other payable | |||||||||||
| Accrued liabilities and other payables | |||||||||||
| Total current liabilities | |||||||||||
| Total Liabilities | |||||||||||
| Commitments and contingencies | |||||||||||
| Stockholders’ Deficit | |||||||||||
| Common stock, $0.001 par value, 75,000,000 shares authorized; 7,106,000 and 7,106,000 shares issued and outstanding as of April 30, 2026 and July 31, 2025 | |||||||||||
| Additional paid-in-capital | |||||||||||
| Accumulated deficit | |||||||||||
| Total Stockholders’ Deficit | |||||||||||
| TOTAL LIABILITIES AND STOCKHOLDERS’ DEFICIT |
Loading...
